Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Elsevier MDL
ETH Zurich licenses DiscoveryGate content platform
July 4th, 2007
Elsevier MDL is pleased to announce that ETH Zurich (Swiss Federal Institute of Technology) has licensed the full online DiscoveryGate(R) content platform. DiscoveryGate serves tens of thousands of scientists and researchers at more than 400 commercial, academic and government institutions worldwide and is supported on both the Microsoft Windows(R) and Apple Macintosh(R) OS X platforms. Hands-on experience with DiscoveryGate in academia prepares students for success in today's highly competitive job market, as the platform is widely deployed in the commercial research environment. "DiscoveryGate enables chemistry researchers, staff and students alike, to access a very...
Source: Medical Patent Law Weekly (2007-07-04)
|
